Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D

NCT01312441 is registered in ClinicalTrials.gov with Albany College of Pharmacy and Health Sciences as lead sponsor.

NCT NCT01312441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01312441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D
Lead sponsor
Albany College of Pharmacy and Health Sciences
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2011
Completion date
August 31, 2015
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure chronic requiring hemodialysis, vitamin d deficiency